- Current report filing (8-K)
April 22 2009 - 4:06PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
________________
FORM 8-K
|
CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
EXCHANGE ACT OF 1934
|
|
Date of report (date of earliest event reported):
April 22, 2009
|
|
CORE LABORATORIES N.V.
(Exact name of registrant as specified in its charter)
001-14273
(Commission File Number)
The Netherlands
|
Not Applicable
|
(State or other jurisdiction of incorporation or
organization)
|
(I.R.S. Employer Identification No.)
|
|
|
Herengracht 424
|
|
1017 BZ Amsterdam
|
|
The Netherlands
|
Not Applicable
|
(Address of principal executive offices)
|
(Zip Code)
|
|
|
Registrant's telephone number, including area code:
(31-20)
420-3191
Check the appropriate below if the
Form 8-K filing is intended to simultaneously satisfy the filing obligation of
the registrant under any of the following provisions:
___
|
Written communications
pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
|
___
|
Soliciting material
pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
|
___
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2 (b))
|
|
|
___
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4 (c))
|
|
|
Item 2.02 Results of Operations and Financial Condition
On April 22, 2009, Core Laboratories N.V. issued a press release
announcing its financial results for the period ending March 31, 2009. The
full text of the press release is set forth in Exhibit 99.1 attached hereto.
The information in this Report and the exhibit attached hereto shall not be
deemed "filed" for purposes of Section 18 of the Securities Exchange Act of
1934, as amended (the "Exchange Act"), nor shall they be deemed incorporated by
reference in any filing under the Securities Act of 1933, as amended, or the
Exchange Act, except as shall be expressly stated by specific reference in such
filing.
Item 9.01 Financial Statements and Exhibits
99.1
Press release issued on April 22, 2009*
* This exhibit is intended to be furnished and shall not be deemed "filed"
for purposes of the Exchange Act.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
|
|
|
|
|
|
|
|
|
Core Laboratories N.V.
|
|
|
|
|
|
|
|
Dated: April 22, 2009
|
|
By
|
|
/s/ Richard L. Bergmark
|
|
|
|
|
|
|
Richard L. Bergmark
|
|
|
|
|
|
|
Chief Financial Officer
|
|
|
CORE LABORATORIES N.V.
EXHIBIT INDEX TO FORM 8-K
|
|
|
EXHIBIT NO.
|
|
ITEM
|
|
|
|
99.1
|
|
Press release issued on April 22, 2009*
|
* This exhibit is intended to be furnished and shall not be deemed "filed"
for purposes of the Exchange Act.
Core Laboratories (NYSE:CLB)
Historical Stock Chart
From May 2024 to Jun 2024
Core Laboratories (NYSE:CLB)
Historical Stock Chart
From Jun 2023 to Jun 2024